PatientSpotlight, by PanaceaIntelPatientSpotlight

Topic · Cardiometabolic

Biomarkers

Coverage of the biomarker tools the field uses to identify disease and stratify treatment - imaging, plasma, tissue, and genetic markers - and how validation work is reshaping which tools matter when. 3 pieces on biomarkers in Cardiometabolic, newest first within each collection.

← All topics
FilterAll (51)Oncology (15)Rare Disease (1)Immunology (3)Neurology (18)Cardiometabolic (3)Respiratory (8)Women's Health (2)Ophthalmology (1)

Signals

1
SignalNEWMay 5, 2026

Heart failure with reduced ejection fraction therapy moves beyond four-pillar standard

Vericiguat addition, mechanism-targeted programs, and emerging genetically-defined HFrEF approaches are reshaping the post-four-pillar landscape.

TreatmentPipelineBiomarkersDrug development

Snapshots

2
SnapshotNEWMay 7, 2026

Lipid management therapy reference (2026)

Reference snapshot of lipid management therapy across foundational, add-on, and emerging tiers.

TreatmentBiomarkersDelivery
SnapshotNEWMay 5, 2026

HFrEF therapy reference (2026)

Reference snapshot of HFrEF therapy across the four-pillar standard, additional approved options, and emerging mechanism classes.

TreatmentBiomarkersPatient journey